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Inflammation is critical for the development of obesity-associated metabolic disorders. This
study aims to investigate the role of mitogen-activated protein kinase phosphatase 2 (MKP-
2) in inflammation during macrophage-adipocyte interaction.
Methods
White adipose tissues (WAT) from mice either on a high-fat diet (HFD) or normal chow (NC)
were isolated to examine the expression of MKP-2. Murine macrophage cell line RAW264.7
stably expressing MKP-2 was used to study the regulation of MKP-2 in macrophages in re-
sponse to saturated free fatty acid (FFA) and its role in macrophage M1/M2 activation. Mac-
rophage-adipocyte co-culture system was employed to investigate the role of MKP-2 in
regulating inflammation during adipocyte-macrophage interaction. c-Jun N-terminal kinase
(JNK)- and p38-specific inhibitors were used to examine the mechanisms by which MKP-2
regulates macrophage activation and macrophage-adipocytes interaction.
Results
HFD changed the expression of MKP-2 in WAT, and MKP-2 was highly expressed in the
stromal vascular cells (SVCs). MKP-2 inhibited the production of proinflammatory cytokines
in response to FFA stimulation in macrophages. MKP-2 inhibited macrophage M1 activation
through JNK and p38. In addition, overexpression of MKP-2 in macrophages suppressed in-
flammation during macrophage-adipocyte interaction.
Conclusion
MKP-2 is a negative regulator of macrophage M1 activation through JNK and p38 and inhib-
its inflammation during macrophage-adipocyte interaction.
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Introduction
Obesity—a rapidly emerging major public health issue worldwide—is associated with an in-
creased risk of insulin resistance and type 2 diabetes (T2D) [1]. Obesity-associated inflamma-
tion in adipose tissue is critical in the initiation and progression of systemic insulin resistance
[2]. Generally, expansion of adipose tissue in obesity leads to increased macrophage infiltration
and inflammation with enhanced production of proinflammatory cytokines such as tumor ne-
crosis factor α (TNF-α) and interleukin 6 (IL-6). This is accompanied by an increased release
of free fatty acids (FFAs) and dysregulated secretion of adipocyte- and macrophage-derived
factors, including leptin, adiponectin, and resistin [3,4]. These mediators (collectively known
as adipokines) can act in a paracrine or autocrine fashion to further exacerbate adipose tissue
inflammation and reduce insulin sensitivity [5].
In mice, macrophages are the major immune cells infiltrated in adipose tissue in response to
high-fat diet (HFD) [6]. Adipose tissue macrophages (ATMs) are a prominent source of proin-
flammatory cytokines such as TNF-α, IL-6, and IL-1β that can block insulin action [4,7]. Dur-
ing HFD-induced progressive obesity, ATMs undergo a phenotypic switch from an anti-
inflammatory M2 polarization state to a proinflammatory M1 polarization state [7]. M1 or
“classically activated”macrophages promote insulin resistance, whereas M2 or “alternatively
activated”macrophages are protective against the development of insulin resistance. M1 mac-
rophage activation can be induced in vitro by proinflammatory mediators such as interferon
(IFN)-γ and lipopolysaccharides (LPS) [8], while M2 macrophages can be induced by exposure
to IL-4 and IL-13 [7,9].
Mitogen-activated protein kinase (MAPK) phosphatases (MKPs) or dual specificity phos-
phatases (DUSPs) are major negative regulators of MAPKs [10]. They inactivate MAPKs
through dephosphorylation of threonine and/or tyrosine residues essential for the activation of
MAPKs. Members of MKP family have been shown to play diverse roles in metabolism. For in-
stance, MKP-4 was reported to inhibit insulin-stimulated adipogenesis and glucose uptake in
adipocytes [11]. In addition, it played a protective role in the development of stress-induced in-
sulin resistance [12]. Wu et al showed that mice lacking MKP-1 were resistant to diet-induced
obesity due to enhanced energy expenditure [13]. More recently, MKP-3 was shown to pro-
mote hepatic gluconeogenesis by dephosphorylation of forkhead transcription factor FOXO1
[14]. MKP-2 is a 42-kDa inducible phosphatase known to be upregulated in response to growth
factors, phorbol 12-myristate 13-acetate (PMA), oxidative stress, and UV light as well as
LPS [15]. Interestingly, one study on MKP-2 showed that it is a negative regulator of c-Jun
N-terminal kinase (JNK) and p38 in macrophages and that it inhibits the expression of proin-
flammatory cytokines in response to LPS [16]. Cornell et al, on the other hand, showed that
MKP-2 is an extracellular signal-regulated kinase (ERK) phosphatase and in response to LPS,
inhibits MKP-1 expression through ERK to enhance the expression of inflammatory cytokines
such as TNF-α in macrophages [15]. In addition to such controversies on its substrates, the
role of MKP-2 in macrophage M1/M2 activation and its function in ATMs are not well studied.
In this study, we showed that MKP-2 inhibits inflammatory activation of macrophages and




Animal experiments were approved by the Institutional Animal Care and Use Committee of
National University of Singapore. 5–6 weeks old male C57BL/6 mice (4–5 mice per group)
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were fed with a chow diet (NC) or a high-fat diet (HFD; TD03584, Harlan) (35.2% fat, 20.4%
protein, and 36.1% carbohydrate by weight) for 8 weeks. The mice were sacrificed by CO2 gas
asphyxiation without fasting. Adipose tissue was isolated and total RNA extracted for cDNA
synthesis. To isolate stromal vascular cells (SVCs), adipose tissue was minced into fine pieces
immediately after CO2 asphyxiation. Minced samples were digested in HEPES-buffered
DMEM supplemented with 2.5% bovine serum albumin (BSA) and 40μg/mL collagenase at
37°C on an orbital shaker (200rpm) for 45–60 min. The digested samples were passed through
a sterile 100μm nylon mesh and the suspension was placed on ice for 20min followed by centri-
fugation at 1000rpm for 5min. The floating adipocytes and the pelleted SVCs were separated
for RNA extraction. The red blood cells within SVCs were lysed in ACK (Ammonium-Chlo-
ride-Potassium) Lysing Buffer (Lonza).
Cell culture
RAW264.7 (ATCC) macrophage cell line was maintained in RPMI1640 medium (Invitrogen)
containing 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen) and 1% Pen/Strep (Invi-
trogen). 3T3-L1 preadipocytes, a preadipocyte cell line commonly employed as a preadipose cell
model [17], were maintained in DMEMmedium (Invitrogen) containing 10% bovine serum
(Invitrogen), 1% Pen/Strep (Invitrogen), and 1mM sodium pyruvate (Invitrogen). Cells were in-
cubated at 37°C in a humidified 5% CO2/95% air atmosphere. Differentiation of 3T3-L1 preadi-
pocytes into mature adipocytes was performed using insulin (Sigma), dexamethasone (Sigma),
and 3-isobutyl-1-methly-xanthine (Sigma) for 8 days as described [18]. Macrophage M1 pheno-
type was induced by culturing RAW264.7 in presence of 20ng/mL of mouse recombinant IFN-γ
(BD Pharmingen) for 12h followed by 100ng/mL LPS (Sigma) stimulation for another 12h. M2
activation of macrophages was induced by either 20ng/mL IL-4 (Biolegend) or 20ng/mL IL-13
(Biolegend) for 12h. Palmitate-BSA (Sigma) complex preparation was performed as described
previously [19]. Briefly, palmitate was dissolved in 95% ethanol at 60°C and mixed with pre-
warmed 10% FFA-free BSA (Sigma), yielding a stock concentration of 7.5mM.
Dual luciferase reporter assay
2 × 105 RAW264.7 cells were co-transfected with 50 ng AP-1 reporter construct, 50ng
pcDNA3.1-MKP-2 together with 10 ng of pRL-null plasmid using Lipofectamine LTX reagent
(Invitrogen). Equal amounts of pcDNA3.1 empty vector were transfected as control. Reporter
activity was determined with Promega Dual Luciferase Assay System (Promega). Firefly lucif-
erase values were normalized for transfection efficiency by means of the Renilla luciferase activ-
ity that is constitutively expressed by pRL-null.
Generation of MKP-2 overexpressing RAW264.7 cells
pcDNA3.1-MKP-2 or pcDNA3.1 empty vector was transfected into RAW264.7 cells using
Lipofectamine LTX (Invitrogen). Transfected cells were cultured in RPMI complete medium
containing 500μg/mL G418 (Clontech), and the medium was changed every 2 days for 14 days.
Cell colonies were picked after selection. MKP-2 mRNA and protein expression were measured
to determine MKP-2 expression. Selected cells were maintained in complete medium in the
presence of 100ng/mL G418.
Quantitative real-time polymerase chain reaction
Total RNA was extracted from cultured cells using TRIzol (Invitrogen) and used for cDNA
synthesis using ImProm-II Reverse Transcription System (Promega). Quantitative real-time
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PCR (qRT-PCR) was performed with an Applied system 7900 Detection System using Fast
SYBR Master Mix (Applied Biosystems, B.V). The following mouse primers were used:
forward primer 5’-GCAGTGCCTACCATGCTG-3’ and reverse primer 5’-ATGGCTTCCAT-
GAACCAGGAG-3’ forMkp-2; forward primer 5’-CTTGCAGATGAAGCCTTTGAAGA-3’
and reverse primer 5’-GGAACGCACCTTTCTGGACA-3’ for Interleukin-12 p40 (Il12p40);
forward primer 5’-CTCCAAGCCAAAGTCCTTAGAG-3’ and reverse primer 5’-
AGGAGCTGTCATTAGGGACATC-3’ for Arginase1 (Arg1); forward primer 5’-AGAAGG-
GAGTTTCAAACCTGGT-3’ and reverse primer 5’-GTCTTGCTCATGTGTGTAAGTGA-3’
for Chitinase 3-like 3 (Chi3l3); forward primer 5’-TGAGAAAGGCTTTAAGAACTGGG-3’ and
reverse primer 5’-GACCACCTGTAGTGATGTGGG-3’ forMacrophage galactose N-acetyl-
galactosamine specific lectin 1 (Mgl1); forward primer 5’-GCTCTTACTGACTGGCATGAG-3’
and reverse primer 5’-CGCAGCTCTAGGAGCATGTG-3’ for Interleukin-10 (Il-10); forward
primer 5’-GACAACTTTGGCATTGTG-3’ and reverse primer 5’-ATGCAGGGAT-
GATGTTCTG-3’ for Glyceraldehyde 3-phosphate dehydrogenase (Gapdh). Levels of mRNA
were calculated using 2–ΔΔ Ct method [20] and normalized to those of GapdhmRNA.
Co-culture of adipocytes and macrophages
Adipocyte-macrophage co-culture was performed in a contact system. Briefly, the differentiat-
ed 3T3-L1 adipocytes were cultured in a six-well plate and 1x 105 RAW264.7 cells were plated
onto 3T3-L1 adipocytes. The cells were co-cultured for 24-h followed by 24-h palmitate stimu-
lation. Culture supernatants from the co-culture were harvested. Supernatants of separately
cultured adipocytes and macrophages, numbers of which were equal to those in the contact
system, were used as control. All the cytokines production was normalized to the total protein
of the cell lysates.
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of IL-6 and TNF-α in culture supernatants were determined by IL-6 and
TNF-α ELISA kits (BD Pharmingen). Monocyte chemotactic protein 1 (MCP-1) concentration
was determined using an ELISA kit from eBioscience.
Western blot
Whole-cell lysates were separated by 10% sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE), and western blotting was performed using antibodies against MAPK
(Cell signaling), MKP-2 (Santa cruz), and β-actin (Cell signaling). Immunoblots were devel-
oped with enhanced chemiluminescence (ECL) donkey anti-rabbit IgG linked to horseradish
peroxidase secondary antibodies (GE Healthcare) and SuperSignal West Dura Chemilumines-
cent Substrate (Thermo scientific). The blots were exposed to Amersham Hyperfilm ECL and
MP Autoradiography Films (GE Healthcare). The intensity of the indicated bands was mea-
sured using ImageJ software.
JNK and p38 inhibition
RAW264.7 cells were pretreated with either JNK inhibitor SP600125 (20μM) (Sigma) or p38
inhibitor SB23580 (20μM) (Sigma) for 1h. After pretreatment, the cells were stimulated with
IFNγ plus LPS for 0h, 0.5h, 1h and 3h to examine the activation of JNK or the phosphorylation
of ATF2 by western blot using antibody against phosphor (p)-JNK, p-ATF2, JNK, and ATF2.
To examine M1, M2 or inflammatory gene expression, after pretreatment with the respective
inhibitor, cells were stimulated with M1 activators in the presence of SP600125 (20μM) or
MKP-2 Inhibits Inflammation
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SB23580 (20μM) for indicated times or co-cultured with 3T3-L1 adipocytes for 24 h. DMSO
was used as a vehicle control.
Statistical analysis
Data were expressed as the mean±standard error of the mean (SEM). Statistical analysis was
performed using two-tailed student’s unpaired t-test. A p-value<0.05 was considered to be
statistically significant.
Results
Nutrition conditions modulate the expression of MKP-2 in adipose tissue
Adipose tissue dysfunction is a primary defect in obesity and obesity-associated metabolic dis-
orders such as T2D [21]. To examine the possible role of MKP-2 in adipose tissue in obesity,
5–6 weeks old male C57BL/6J mice were fed with either HFD or NC for 8 weeks and the ex-
pression of MKP-2 in WAT was examined. We found a significant decrease in the expression
of MKP-2 in WAT from HFD-fed mice compared to that from NC-fed mice (Fig. 1A). Further-
more, the expression of MKP-2 was significantly higher in SVCs isolated fromWAT as com-
pared to that in adipocytes from NC- or HFD-fed mice (Fig. 1A). Although the expression of
MKP-2 in adipocytes was comparable between NC- and HFD-fed mice, there was a significant
decrease in MKP-2 expression in SVCs from HFD-fed mice compared with SVCs from NC-fed
mice (Fig. 1A). These results suggest a possible role of MKP-2 in WAT inflammation.
FFA increases MKP-2 expression in macrophages
In obesity, increased release of FFAs results in the activation of inflammatory signaling path-
ways, recruitment of macrophages, and the production of inflammatory mediators, which con-
tribute to the development of metabolic disorders such as insulin resistance [3]. Macrophages
are the major source of inflammatory cytokines in WAT [4]. To understand the regulation of
inflammatory cytokine expression in macrophages by MKP-2 in obesity, we assessed the ex-
pression of MKP-2 in macrophages in response to palmitate, one of the most abundant saturat-
ed FFAs in plasma [22]. Murine macrophage cells, RAW264.7, were stimulated with palmitate
for various time periods to determine the expression of MKP-2. As shown in Fig. 1B, MKP-2
mRNA expression was significantly increased at 3 and 6h after FFA stimulation compared
with that in cells without stimulation. In line with the increased mRNA expression, we detected
increased MKP-2 protein expression in RAW264.7 cells after palmitate stimulation (Fig. 1C).
Thus, MKP-2 expression was increased upon FFA stimulation, suggesting the possible regula-
tory function of MKP-2 in FFA-induced inflammation in macrophages.
MKP-2 inhibits TNF-α expression and JNK activation in macrophages
upon FFA stimulation
To further understand the role of MKP-2 in regulating FFA-mediated inflammatory cytokine
expression in macrophages, we transfected promoter construct of AP1, a major target of
MAPK pathways [23], with either a full length mouse MKP-2 cDNA construct or a vector con-
trol into RAW264.7 cells. Dual luciferase assay was performed to assess AP-1 promoter activity
in response to FFA. We observed that palmitate significantly increased AP-1 promoter activity
in macrophages, while overexpression of MKP-2 significantly inhibited AP-1 promoter activity
with or without palmitate stimulation (Fig. 1D). To elucidate the regulatory role of MKP-2 in
the expression of inflammatory cytokines in response to FFA, we generated RAW264.7 cells
stably expressing mouse MKP-2. qRT-PCR and western blot analysis of MKP-2 expression
MKP-2 Inhibits Inflammation
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confirmed the overexpression of MKP-2 in selected cells at both mRNA and protein levels
(Fig. 2A).
Adipose tissue-derived TNF-α, mainly from ATMs, is a MAP kinase target gene and has
been shown to be a major player in obesity-induced insulin resistance and T2D [2,24,25]. To
examine the role of MKP-2 in the regulation of TNF-α expression in macrophages in response
to FFA, we stimulated MKP-2 overexpressing macrophages and control cells with different
concentrations of palmitate. Consistent with a previous study [19], palmitate induced TNF-α
Fig 1. Modulation of MKP-2 expression in adipose tissue by HFD feeding and in macrophages by FFA stimulation. (A)WAT was isolated frommice
fed with either a chow diet (NC) or a high-fat diet (HFD) for 8 week (4–5 mice per group). SVCs and adipocytes were isolated from the WAT to examine the
expression ofMkp-2 by quantitative real-time PCR (qRT-PCR). (B) Mkp-2 expression was determined by qRT-PCR in RAW264.7 in response to 50μM
palmitate stimulation. (C)MKP-2 protein expression was examined by western blot analysis in RAW264.7 in response to 50μM palmitate stimulation. The
level of β-actin was examined as loading control. The intensity of the MKP-2 bands on the blots was quantified by ImageJ showing mean ± SEM from three
independent experiments normalized to β-actin. (D)RAW264.7 cells were transfected with pcDNA3.1 or pcDNA3.1-MKP-2 plasmids together with AP-1
reporter plasmid and Renilla luciferase reporter vector. Dual luciferase assay was performed to assess AP-1 activity in response to 50μM FFA stimulation for
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production in macrophages in a dose-dependent manner. Interestingly, overexpression of
MKP-2 significantly inhibited TNF-α production in response to FFA stimulation (Fig. 2B).
The substrates of MKP-2 and its role in regulating cytokines expression in macrophages are
controversial [15]. To further study the mechanism by which MKP-2 regulates TNF-α expres-
sion in macrophages in response to FFA, MKP-2 overexpressing macrophages and control
cells were stimulated with palmitate to examine MAP kinase activation. We found that JNK ac-
tivation was increased at 3 and 6h upon FFA stimulation (Fig. 2C). Overexpression of MKP-2
significantly decreased the activation of JNK in response to palmitate (Fig. 2C). However, p38
activity could not be detected under the same condition. Taken together, the results indicate
that upon FFA stimulation, MKP-2 regulates TNF-α expression in macrophages possibly
through JNK.
MKP-2 expression in macrophages suppresses inflammatory cytokine
production during adipocyte-macrophage interaction
Next, we performed in vitromacrophage-adipocyte co-culture experiment to further study the
regulation of MKP-2 in inflammation during adipocyte-macrophage interaction. MKP-2 over-
expressing macrophages were co-cultured with differentiated 3T3-L1 adipocytes for 24h either
with or without palmitate stimulation. Interestingly, we observed significant increase in the lev-
els of inflammatory cytokines, including IL-6, TNF-α, and chemokine MCP-1 in macrophage-
Fig 2. Overexpression of MKP-2 inhibits TNF-α expression and JNK activation in macrophages in response to FFA. (A)MKP-2 expression in MKP-2
stably transfected RAW264.7 was examined by qRT-PCR and western blot. (B) Control and MKP-2 overexpressing RAW264.7 cells were stimulated with
indicated concentrations of palmitate for 24 h, and culture supernatants were harvested to measure TNF-α production by ELISA. (C)Control and MKP-2
overexpressing RAW264.7 cells were stimulated with 750μM palmitate for the indicated time points and cell lysates were prepared to examine JNK
expression and activation. (D) The intensity of the p-JNK bands on the blots was quantified by ImageJ showing mean ± SEM from three independent
experiments normalized to total JNK. Data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001.
doi:10.1371/journal.pone.0120755.g002
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adipocyte coculture without palmitate stimulation (Fig. 3A). FFA stimulation further increased
the production of IL-6 and TNF-α, but not MCP-1. Importantly, overexpression of MKP-2 in
macrophages greatly suppressed the production of inflammatory mediators, including IL-6,
TNF-α, and MCP-1 with or without palmitate stimulation (Fig. 3A). Furthermore,Mkp-2 was
more highly expressed in RAW264.7 than 3T3-L1 adipocytes with or without palmitate stimu-
lation (Fig. 3B). Even though the expression of MKP-2 was threefold higher in MKP-2 overex-
pressing RAW264.7 than pcDNA3.1-transfected RAW264.7, the expression ofMkp-2 in
different groups of co-culture cells was comparable but lower than pcDNA3.1-transfected
RAW264.7 cells, which is likely due to the addition of theMKp-2 lower adipocytes in the
co-culture samples (Fig. 3B). Given thatMkp-2 is highly expressed in macrophages, these adi-
pocyte-macrophage interaction data provide evidence that overexpression of MKP-2 in
macrophages suppresses the production of inflammatory cytokines during adipocyte-
macrophage interaction.
Fig 3. Overexpression of MKP-2 in macrophages inhibits inflammatory cytokine production duringmacrophage-adipocyte interaction. (A-B)
Control or MKP-2 overexpressing RAW264.7 (1x105) and differentiated 3T3-L1 cells were cultured either alone or together and stimulated with or without
750μM palmitate overnight. IL-6, TNF-α, and MCP-1 levels in the supernatants were determined by ELISA. Cytokine production was normalized to total
protein of the cell lysates. mRNA of each sample was harvested to examineMkp-2 expression by qRT-PCR. Ct, control; Co, co-culture. (C)Control and MKP-
2 overexpressing RAW264.7 cells were treated with conditioned medium (CM) derived from 3T3-L1 adipocytes treated with BSA (CM-B) or 750μM FFA
(CM-F) for 24 h. Regular media containing BSA (RM-B) or 750μM FFA (RM-F) were used as control. Supernatants were harvested for ELISA analysis. (D)
CM derived from vector transfected or MKP-2 overexpressing RAW264.7 treated with BSA or 750μM FFA were used to treat 3T3-L1 adipocytes for 24 h.
Regular media containing BSA or 750μMFFA were used as control. Supernatants were harvested for ELISA analysis. RM, regular media; CM-pcDNA3.1,
conditioned media derived from pcDNA3.1-transfected RAW264.7; CM-MKP-2, conditioned media derived fromMKP-2 transfected RAW264.7. Data shown
are representative of three independent experiments with similar results. Data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001.
doi:10.1371/journal.pone.0120755.g003
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To further investigate the regulatory role of MKP-2 in the initiation of inflammatory
changes in both cells by production of secreted factors, we treated control or MKP-2 overex-
pressing RAW264.7 with CM derived from 3T3-L1 adipocytes treated with BSA or FFA for
24 h. It was observed that IL-6 and MCP-1 were not produced by RAW264.7 when treated
with regular media (RM) with BSA or FFA (Fig. 3C). Interestingly, CM from 3T3-L1 adipo-
cytes significantly increased IL-6, TNF-α, and MCP-1 production in macrophages (Fig. 3C).
Importantly, overexpression of MKP-2 in RAW264.7 significantly reduced IL-6 and TNF-α
but not MCP-1 production when cultured with CM derived from 3T3-L1 adipocytes (Fig. 3C).
These data demonstrate that secreted factors from adipocytes trigger inflammatory cytokine
expression in macrophages and MKP-2 expression in macrophages inhibits IL-6 and TNF-α
production in macrophages induced by adipocyte-derived factors. Additionally, we also treated
3T3-L1 adipocytes with CM derived from RAW264.7 or MKP-2 overexpressing RAW264.7
treated with BSA or FFA. Interestingly, we found significant increase in IL-6, TNF-α, and
MCP-1 levels after CM treatment (Fig. 3D). Importantly, only MCP-1 production was signifi-
cantly lower in adipocytes when treated with CM derived fromMKP-2 overexpressing
RAW264.7 compared with cells treated with CM derived from control RAW264.7 (Fig. 3D).
Thus, different secreted factors from macrophages are responsible for MCP-1 or IL-6/TNF-a
expression by adipocytes and MKP-2 expression in macrophage inhibited the expression of
factors that induce MCP-1 production in adipocytes. Taken together, the data suggest that
MKP-2 expression in macrophages negatively regulates the production of IL-6, TNF-α and al-
ters the expression of factors inducing MCP-1 production from adipocytes during adipocyte-
macrophage interaction.
MKP-2 expression in macrophages inhibits macrophage M1 activation
Obesity is accompanied by macrophage infiltration into adipose tissue and a transition of
ATMs fromM2 to M1 activation status [7,26]. M1 macrophages accumulated in adipose tissue
produce various inflammatory mediators such as IL-6 and TNF-α and promote the develop-
ment of insulin resistance [8,11]. M2 macrophages, on the other hand, are anti-inflammatory
and important for maintaining metabolic homeostasis in WAT [27]. To examine the function
of MKP-2 in ATM activation, control and MKP-2 overexpressing macrophages were stimulat-
ed with IFN-γ for 12h followed by stimulation with LPS to induce macrophage M1 activation
[28]. We found that MKP-2 overexpressing macrophages produced significantly reduced
amount of IL-6 and TNF-α compared with control cells (Fig. 4A). The expression of Il-12p40,
one of the M1 markers, was also significantly decreased in MKP-2 overexpressing cells
(Fig. 4B). These results demonstrate that MKP-2 inhibits macrophage M1 activation. To exam-
ine the specificity of MKP-2 in macrophages for MAPK in response to M1 activation, the ex-
pression and activation of ERK, JNK, and p38 were determined. We found that the activation
of all the three groups of MAPK was induced at 30 min and weaned off at 3 h after M1 stimula-
tion (Fig. 4C and D). Overexpression of MKP-2 significantly inhibited the activation of JNK
and p38, but not ERK, upon M1 activation (Fig. 4C and D). Taken together, the results suggest
that MKP-2 may inhibit macrophage M1 activation by inhibiting JNK and p38 activation.
MKP-2 expression in macrophages enhances macrophage M2
activation
Next, we examined if MKP-2 plays a role in macrophage M2 activation. We stimulated MKP-2
overexpressing or control cells with IL-4 to induce M2 activation. The expression of M2 mark-
ers, including Arg1, Chi3l3,Mgl1, and Il-10 was found to be significantly increased in MKP-2
overexpressing cells compared with that in control cells (Fig. 5A). Furthermore, we also found
MKP-2 Inhibits Inflammation
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that overexpression of MKP-2 increased the expression of M2 markers in response to IL-13,
another factor known to induce macrophage M2 activation (Fig. 5B). Thus, these results dem-
onstrate that MKP-2 modulates macrophage phenotypic switch by inhibiting M1 activation
and promoting M2 activation.
Differential regulation of macrophage M1 and M2 activation by JNK and
p38
Our study demonstrate that MKP-2 plays important roles in macrophage M1/M2 activation
and inflammation during macrophage-adipocyte interaction possibly through JNK and/or p38.
Next, we treated macrophages with JNK- or p38-specific inhibitor to examine their regulatory
Fig 4. Overexpression of MKP-2 inhibits macrophage M1 activation and JNK/p38 activation.Control and MKP-2 overexpressing RAW264.7 cells were
primed with 20 ng/mL IFN-γ for 12h followed by stimulation with 100 ng/mL LPS for another 12h. Culture supernatants were harvested for ELISA to detect IL-
6 and TNF-α production (A), and total RNA was extracted for qRT-PCR of Il-12p40 (B). Cell lysates were harvested at 0 hour (h), 0.5h, 1h and 3h after M1
activator stimulation to determine the expression and activation of ERK, JNK, and p38 by western blot analysis (C). (D) The intensity of phospho (p)-ERK, p-
JNK, and p-p38 bands on the blots were quantified by ImageJ showing mean ± SEM from three independent experiments normalized to total ERK, JNK, and
p38. Data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001.
doi:10.1371/journal.pone.0120755.g004
MKP-2 Inhibits Inflammation
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roles in macrophage M1 and M2 activation. As shown in Fig. 6A, treatment of macrophages
with 20μM JNK-specific inhibitor, SP600125, greatly inhibited JNK activation in response to
M1 stimulation, whereas treatment with 20μM p38-specific inhibitor, SB23580, reduced the
phosphorylation of ATF2, a major substrate of p38. Consistent with previous findings, JNK in-
hibition resulted in reduced IL-6 and TNF-α production by macrophages in response to M1 ac-
tivation (Fig. 6B). On the other hand, the expression of M2 markers, including Arg1,Mgl1, and
Chi3i3, was significantly increased in macrophages upon M2 activation following JNK inhibi-
tion (Fig. 6C). Therefore, JNK activation promotes macrophage M1 activation and inhibits M2
activation. Similarly, inhibition of p38 significantly reduced the production of IL-6 and TNF-α
by macrophages in response to M1 activation (Fig. 6D). The expression of M2 genes, including
Arg1 and Chi3i3, appears to require p38, as macrophages treated with p38-specific inhibitor ex-
pressed significantly lower levels of Arg1 and Chi3i3 (Fig. 6E). Interestingly, unlike Arg1 and
Chi3i3, the expression ofMgl1 was significantly increased in response to M2 activation upon
p38 inhibition.
To understand the regulation of macrophage-adipocyte interaction by JNK and p38, control
RAW264.7 and MKP-2 overexpressing RAW264.7 were pretreated with JNK- or p38-specific
inhibitor before being co-cultured with adipocytes. As shown in Fig. 6F, inhibition of JNK re-
sulted in significantly reduced IL-6 and TNF-α production during the interaction of
pcDNA3.1-transfected RAW264.7 with adipocytes, whereas p38 inhibition resulted in signifi-
cantly reduced IL-6, but not MCP-1 and TNF-α following macrophage-adipocyte interaction
(Fig. 6F). We also observed that inhibiting both JNK and p38 significantly reduced the produc-
tion of all three cytokines during pcDNA3.1-transfected RAW264.7 co-cultured with adipo-
cytes (Fig. 6F). Consistently, MKP-2 overexpression in RAW264.7 cells resulted in significantly
Fig 5. Overexpression of MKP-2 enhances macrophage M2 activation. (A) Control and MKP-2 overexpressing RAW264.7 cells were stimulated with 20
ng/mL IL-4 for 12h and total RNA was extracted to analyze the expression of M2 markers by qRT-PCR. (B)Control and MKP-2 overexpressing RAW264.7
cells were stimulated with 20 ng/mL IL-13 for 12h and total RNA was extracted to analyze expression of M2 markers by qRT-PCR. The data shown are
representative of three independent experiments with similar results. Data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001.
doi:10.1371/journal.pone.0120755.g005
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reduced expression of all the three cytokines when co-cultured with adipocytes (Fig. 3A and
6F). p38 inhibition in MKP-2 overexpressing macrophages resulted in further reduction in
MCP-1 and IL-6 production, while JNK inhibition led to further reduced IL-6 and TNFα pro-
duction (Fig. 6F). Interestingly, only IL-6 production was further reduced upon the inhibition
of both JNK and p38 inhibition in MKP-2 overexpressing RAW264.7 cells. These data suggest
that JNK and p38 activation in macrophages differentially regulate cytokine expression and
that MKP-2 potentially targets JNK and p38 to inhibit inflammatory cytokine production dur-
ing adipocyte-macrophage interaction.
Fig 6. Inhibition of JNK and p38 in macrophages suppressed inflammatory cytokine expression in macrophages and in macrophage-adipocyte
interaction. (A) RAW264.7 cells were stimulated with IFN-γ plus LPS in the presence of JNK-specific inhibitor SP600125 (20μM) (Sigma) or p38-specific
inhibitor SB23580 (20μM) for the indicated time points. DMSOwas used as vehicle control. The expression and activation of JNK or ATF2 were determined
by western blot analysis. RAW264.7 cells were pretreated with SP600125 (20μM) followed by stimulation with M1 (B) or M2 (C) activation condition. The
expression of M1 or M2 markers was determined. RAW264.7 cells were pretreated with SB23580 (20μM) followed by stimulation with M1 (D) or M2 (E)
activation condition. The expression of M1 or M2 genes was analyzed. (F) Control and MKP-2 overexpressing RAW264.7 cells were pretreated with
SP600125 (20μM) or SB23580 (20μM) or both for 1h before co-culture with differentiated 3T3-L1 adipocytes for 24h. The concentrations of MCP-1, IL-6, and
TNF-α in culture supernatants were determined by ELISA. Cytokines production was normalized to total protein of the cell lysates. Ct, control; Co, co-culture.
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Discussion
Obesity associated with chronic inflammation in adipose tissue is critical for the development
of insulin resistance and other obesity-associated metabolic disorders [29]. MAPK such as JNK
and p38 are essential regulators of inflammation. MKPs control the magnitude and duration of
MAPK activation to determine the MAPK-regulated biological outcomes. Several MKPs have
been shown to play specific roles in inflammation [30,31]. However, regulatory functions of
MKPs in chronic inflammation in adipose tissue have not been well understood. In this study,
we showed that MKP-2 plays an inhibitory role in inflammatory cytokine expression during
adipocyte-macrophage interaction, suggesting the involvement of this protein in obesity-asso-
ciated inflammation and metabolic disorders.
In obesity, the expanding adipose tissue releases a large numbers of mediators, including
TNF-α, IL-6, and MCP-1 as well as FFA, which can interfere with insulin signaling [3]. FFA is
considered as a primary link between obesity and inflammation. Plasma FFA level is elevated
in obesity and diabetes in both humans and animals, and lowering FFA leads to increased insu-
lin sensitivity [3]. ATMs, a major source of inflammatory mediators such as TNF-α and IL-6
[4], play critical role in WAT inflammation and in the development of insulin resistance [32].
MKP-2 was identified as a molecule encoded by an immediate-early gene [33]. We found that
FFA increased both mRNA and protein expression of MKP-2 in macrophages around 3h after
stimulation (Fig. 1B-C). Interestingly, in mouse WAT, MKP-2 is highly expressed in SVCs
than in adipocytes and HFD decreased its expression in WAT SVCs (Fig. 1A), indicating that
chronic nutrition stress changes the expression of this molecule in leukocytes in the WAT and
a possible role of MKP-2 in WAT inflammation.
The development of adipose tissue inflammation and insulin resistance in obesity is associ-
ated with dysregulation of inflammatory signaling pathways including the MAP kinase path-
ways in adipose tissue. For instance, JNK activation is abnormally increased in adipose tissue
in obesity [34]. Adipose tissue macrophage infiltration and activation is critical for the develop-
ment of adipose tissue inflammation and insulin resistance. Proper regulation of inflammatory
signaling pathway such as JNK in adipose tissue macrophages is important for maintaining ad-
ipose tissue homeostasis. For instance, it has been shown that macrophage-specific deletion of
JNK in mice resulted in impaired macrophage M1 activation, reduced WAT macrophage infil-
tration and inflammation and improved insulin sensitivity in response to HFD [35]. Recently,
it hase been shown that the PB1 domain-containing adaptor NBR1 functions as an organizer
of MEKK3/MKK4, the activators of JNK, in macrophages to regulate JNK activation, ATMM1
activation and adipsoe tissue inflammation in obesity [36]. Myeloid-specific deletion of NBR1
resulted in impaired JNK activation associated with impaired macrophage M1 activation, re-
duced WATmacrophage infiltration and inflammation, and improved insulin sensitivity in re-
sponse to chronic HFD exposure. It is likely that chronic exposure to HFD changes the
expression of components of JNK and other inflammatory signaling pathways, which lead to
adipose tissue inflammation and insulin resistance. The reduced expression of MKP-2 in SVCs
is possibly a part of such changes which requires further investigation.
TNF-α is known as a major inflammatory mediator, which induces insulin resistance in adi-
pose tissue [37]. Here, we discovered that overexpression of MKP-2 inhibits JNK activation
and TNF-α production in macrophages in response to FFA stimulation (Figs. 2B-D). We fur-
ther found that MKP-2 inhibited macrophage M1 activation through both JNK and p38
(Fig. 4C and D). Using JNK- and p38-specific inhibitors, we found that the expression of IL-6
and TNF-α by M1 macrophages requires both JNK and p38 (Fig. 6B and D). These data dem-
onstrate that JNK and p38 promote macrophage M1 activation, and MKP-2 potentially targets
both JNK and p38 to inhibit M1 macrophage activation.
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Till date, there exist several controversies on the substrates of MKP-2. MKP-2 has been
shown to inactivate ERK in B cells and mouse embryonic fibroblasts [38,39]. Al-Mutairi et al
showed that in macrophages MKP-2 inhibits the activation of JNK and p38, but not ERK [16],
whereas Cornell et al demonstrated that in macrophages MKP-2 is an ERK phosphatase [15].
Our observations of decreased JNK and p38 activation and reduced expression of inflammato-
ry cytokines in MKP-2 overexpressing macrophages upon M1 activation support that it is a
negative regulator of both JNK and p38.
Interestingly, we found that in addition to the suppression of macrophage M1 activation,
MKP-2 increases macrophage M2 activation (Fig. 5A and B). We examined the expression of
molecules important for M2 activation, including IRF4, PPAR-γ and the phosphorylation of
STAT6. Our results show that MKP-2 does not regulate their expression or activation (S1 Fig.).
MAPK activation in response to M2 culture condition was not detectable. However, it is possi-
ble that MKP-2 promotes macrophage M2 activation through the inhibition of JNK and p38,
as we observed that inhibition of JNK and p38 increased the expression of M2 marker (Fig. 6C
and E). Currently, we are investigating the mechanism by which MKP-2 regulates macrophage
M2 activation.
Using macrophage-adipocyte co-culture system, we investigated the role of MKP-2 in in-
flammation during the interaction of the two major cell types in adipose tissue. ATMs are
thought to be dominant contributors to the development of obesity-associated inflammation
[32]. It is proposed that there is a paracrine loop involving adipocyte-derived FFAs and macro-
phage-derived TNF-α establishing a vicious cycle that aggravates inflammatory changes in
obese adipose tissue [40]. Interestingly, we observed increased expression of inflammatory cy-
tokines, including IL-6, TNF-α, and MCP-1 upon macrophage-adipocyte interaction without
FFA stimulation (Fig. 3A), suggesting that the interaction between adipocytes and macro-
phages could induce the expression of inflammatory cytokines thereby contributing to the de-
velopment of adipose tissue inflammation. The expression of MCP-1 is not enhanced by FFA
stimulation, suggesting that macrophage infiltration itself could lead to monocyte/macrophage
recruitment into adipose tissue to augment inflammation. MKP-2 expression in macrophages
significantly suppressed the expression of these cytokines with or without FFA stimulation,
demonstrating that macrophages play a major role in inflammation triggered by macrophage-
adipocyte interaction and MKP-2 inhibits such inflammation. Interestingly, we observed sig-
nificantly decreased IL-6 and TNF-α production in MKP-2 overexpressing RAW264.7 when
treated with CM derived from adipocytes (Fig. 3C). CM derived fromMKP-2 overexpressing
RAW264.7 inhibited MCP-1 production in adipocytes (Fig. 3D), suggesting that MKP-2 ex-
pression in macrophages inhibits the expression of secreted factors that important for MCP-1
production during adipocyte-macrophage interaction. In addition, when macrophages were
pretreated with JNK inhibitor, p38 inhibitor, or JNK/p38 inhibitors before being co-cultured
with adipocytes, significant decreases in IL-6, TNF-α, and MCP-1 levels were observed during
adipocyte-macrophage interaction (Fig. 6F), suggesting that both JNK and p38 activation in
macrophages are important for inflammation during adipocyte-macrophage interaction. How-
ever, owing to the complexity of adipose tissue, which harbors various types of cells such as
mature adipocytes, preadipocytes, fibroblasts, and immune cells, it is difficult to completely
mimic the in vivo environment in adipose tissue by co-culturing adipocytes with macrophages.
Additionally, adipocytes are able to secrete proinflammatory mediators such as IL-6, TNF-α,
and MCP-1 [41], which could be regulated by MKP-2. This necessitates further studies to verify
the function of MKP-2 in adipose tissue inflammation and obesity-associated
insulin resistance.
In summary, our study demonstrates that MKP-2 expression in macrophages negatively
regulates macrophage M1 activation and inflammation during adipocyte-macrophage
MKP-2 Inhibits Inflammation
PLOS ONE | DOI:10.1371/journal.pone.0120755 March 27, 2015 14 / 17
interaction by inhibiting JNK and p38 activation. Further understanding the mechanisms by
which MKP-2 regulates adipose tissue inflammation will shed new lights on the regulation of
obesity-associated inflammation and metabolic disorders, including insulin resistance and
T2D.
Supporting Information
S1 Fig. Overexpression of MKP-2 in macrophages does not change the expression and acti-
vation of M2 regulators. (A) Control and MKP-2 overexpressing RAW264.7 cells were stimu-
lated with 20 ng/mL IL-4 for the indicated time points to examine the expression of PPARγ or
the phosphorylation of STAT6 by western blot analysis. (b) IRF4 expression in response to IL-
4 stimulation was determined by quantitative real-time PCR (qRT-PCR). Data shown are rep-
resentative of three independent experiments with similar results. Data are presented as
mean ± SEM. , p<0.05; , p<0.01; , p<0.001.
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